ARTA
ABBV icon

A.R.T. Advisors’s AbbVie ABBV Stock Holding History

A.R.T. Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,151
Closed -$552K – 52
2020
Q4 		$552K Buy
+5,151
New +$495K 2.56% 9
2019
Q4 		– Sell
-112,900
Closed -$8.55M – 1291
2019
Q3 		$8.55M Buy
112,900
+78,600
+229% +$5.39M 0.43% 28
2019
Q2 		$2.49M Sell
34,300
-83,300
-71% -$6.55M 0.14% 186
2019
Q1 		$9.48M Buy
+117,600
New +$9.62M 0.57% 12
2018
Q4 		– Sell
-133,600
Closed -$12.6M – 1268
2018
Q3 		$12.6M Buy
133,600
+130,200
+3,829% +$12.3M 0.58% 18
2018
Q2 		$315K Sell
3,400
-31,200
-90% -$3.05M 0.01% 1090
2018
Q1 		$3.27M Buy
34,600
+28,100
+432% +$3.09M 0.13% 212
2017
Q4 		$628K Sell
6,500
-199,700
-97% -$18.8M 0.03% 802
2017
Q3 		$18.3M Buy
206,200
+144,900
+236% +$11M 0.93% 2
2017
Q2 		$4.44M Sell
61,300
-25,100
-29% -$1.69M 0.24% 86
2017
Q1 		$5.63M Buy
86,400
+60,200
+230% +$3.78M 0.26% 80
2016
Q4 		$1.64M Buy
26,200
+1,900
+8% +$116K 0.1% 327
2016
Q3 		$1.53M Buy
+24,300
New +$1.57M 0.5% 24
2016
Q2 		– Sell
-77,522
Closed -$4.43M – 1314
2016
Q1 		$4.43M Sell
77,522
-197,400
-72% -$11M 0.2% 119
2015
Q4 		$16.3M Buy
274,922
+141,275
+106% +$8.14M 0.77% 4
2015
Q3 		$7.27M Buy
+133,647
New +$8.7M 0.27% 81
2015
Q1 		– Sell
-70,187
Closed -$4.59M – 1391
2014
Q4 		$4.59M Sell
70,187
-6,042
-8% -$381K 0.17% 139
2014
Q3 		$4.4M Buy
76,229
+37,491
+97% +$2.08M 0.2% 124
2014
Q2 		$2.19M Buy
+38,738
New +$2.03M 0.11% 258
2014
Q1 		– Sell
-22,938
Closed -$1.21M – 1295
2013
Q4 		$1.21M Buy
+22,938
New +$1.13M 0.06% 411

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

A.R.T. Advisors's ABBV Position: Q1 2021 in Review

A.R.T. Advisors sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 5,151 shares — an estimated $552K sold.

A.R.T. Advisors first reported a position in ABBV in Q4 2013 and held it in 20 quarters. The position peaked at $18.3M in Q3 2017. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • A.R.T. Advisors reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • A.R.T. Advisors sold 5,151 AbbVie shares in Q1 2021, an estimated $552K.
  • A.R.T. Advisors first reported a position in AbbVie in Q4 2013 and held it in 20 quarters.
  • A.R.T. Advisors's AbbVie position peaked at $18.3M in Q3 2017.
  • 2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on A.R.T. Advisors's 13F filing for Q1 2021, filed 17 May 2021.